These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 16649975)
1. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency. Yuen KC; Dunger DB Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975 [TBL] [Abstract][Full Text] [Related]
2. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235 [TBL] [Abstract][Full Text] [Related]
3. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342 [TBL] [Abstract][Full Text] [Related]
4. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958 [TBL] [Abstract][Full Text] [Related]
5. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function. Gillberg P; Bramnert M; Thorén M; Werner S; Johannsson G Growth Horm IGF Res; 2001 Oct; 11(5):273-81. PubMed ID: 11735245 [TBL] [Abstract][Full Text] [Related]
6. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency. Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347 [TBL] [Abstract][Full Text] [Related]
7. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949 [TBL] [Abstract][Full Text] [Related]
8. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181 [TBL] [Abstract][Full Text] [Related]
9. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults. Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869 [TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome. Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Yuen KC; Dunger DB Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [TBL] [Abstract][Full Text] [Related]
13. [Role of the steroids, SHBG, IGF-1, IGF BP-3 and growth hormone in glucose metabolism disorders during long-term treatment with low doses of glucocorticoids]. Vondra K; Hampl R; Nĕmcová D; Hill M; Hoza J; Kot'átková A; Stárka L; Vrbíková J; Zamrazil V Cas Lek Cesk; 2002 Feb; 141(3):89-95. PubMed ID: 11925670 [TBL] [Abstract][Full Text] [Related]
14. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults. Yuen KC; Dunger DB Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. Hussain MA; Schmitz O; Mengel A; Glatz Y; Christiansen JS; Zapf J; Froesch ER J Clin Invest; 1994 Sep; 94(3):1126-33. PubMed ID: 8083353 [TBL] [Abstract][Full Text] [Related]
17. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency. Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214 [TBL] [Abstract][Full Text] [Related]
18. The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. Yuen K; Ong K; Husbands S; Chatelain P; Fryklund L; Gluckman P; Ranke M; Cook D; Rosenfeld R; Wass J; Dunger D J Clin Endocrinol Metab; 2002 May; 87(5):1989-95. PubMed ID: 11994330 [TBL] [Abstract][Full Text] [Related]
19. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy. Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596 [TBL] [Abstract][Full Text] [Related]
20. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency. Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]